Latest News about AVIR
Recent news which mentions AVIR
Atea Pharma Cuts Workforce By 25%, Expects $15 Million In Cost Savings, Plans Phase 3 Hepatitis C Trial
March 07, 2025
From Benzinga
Earnings Scheduled For March 6, 2025
March 06, 2025
From Benzinga
After Failed COVID-19 Drug Trial, Atea Pharmaceuticals Touts Encouraging Data From Mid-Stage Hepatitis C Study
December 04, 2024
From Benzinga
Atea Pharmaceuticals' COVID-19 Treatment Flunks In Late-Stage Study, Blames 'Constantly Evolving' Virus
September 13, 2024
From Benzinga
Adobe, SelectQuote, Similarweb And Other Big Stocks Moving Lower In Friday's Pre-Market Session
September 13, 2024
From Benzinga
From Benzinga
Tickers
AVIR
From InvestorPlace
Atea Pharmaceuticals' Hepatitis C Virus Candidate Shows Efficacy
January 09, 2024
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023
August 10, 2023
From Benzinga
Why Nvidia Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 30, 2023
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
February 15, 2023
From Benzinga
Atea Pharma's Investigational Dengue Treatment Fast Tracked In US
September 26, 2022
Tickers
AVIR
From Benzinga
Atea Pharmaceuticals To Advance Global Late-Stage COVID-19 Study of Bemnifosbuvir
September 13, 2022
Tickers
AVIR
From Benzinga
Tickers
AVIR
From Motley Fool
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.